These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10470990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphate.
    Giedrojć J, Radziwon P, Klimiuk M, Bielawiec M, Breddin HK, Kłoczko J.
    J Physiol Pharmacol; 1999 Mar; 50(1):111-9. PubMed ID: 10210159
    [Abstract] [Full Text] [Related]

  • 3. [Antithrombotic properties of heparin independent of its anticoagulant activity].
    Krupiński K, Bielawiec M, Breddin HK.
    Acta Haematol Pol; 1994 Mar; 25(3):243-51. PubMed ID: 7992597
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction between the sulfated lactobionic acid (LW 10082) and other antithrombotic agents in animal thrombosis model.
    Giedrojć J, Krupiński K, Breddin HK, Bielawiec M.
    Pol J Pharmacol; 1996 Mar; 48(3):317-22. PubMed ID: 9112669
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y, Honda Y, Kamisato C, Shibano T.
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
    Giedrojc J, Breddin HK.
    Thromb Res; 1991 Jul 01; 63(1):99-110. PubMed ID: 1948825
    [Abstract] [Full Text] [Related]

  • 15. Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate.
    Parker BW, Swain SM, Zugmaier G, DeLap RL, Lippman ME, Wellstein A.
    J Natl Cancer Inst; 1993 Jul 07; 85(13):1068-73. PubMed ID: 7685831
    [Abstract] [Full Text] [Related]

  • 16. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B, Fareed J.
    Thromb Haemost; 1996 Oct 07; 76(4):615-20. PubMed ID: 8903005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models.
    Ji H, Li SP, Cheng X, Cheng HR, Ng TB, Li P, Li NS.
    Gen Pharmacol; 1999 Aug 07; 33(2):207-11. PubMed ID: 10461860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.